---
title: "Theravance Biopharma 10% owner Eli Samaha disposes of USD 119,359 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292110097.md"
description: "Eli Samaha, a 10% owner of Theravance Biopharma, sold 6,964 common shares valued at USD 119,359 on July 6-7. The shares were sold at an average price of $17.04 on July 6 and $17.17 on July 7. Following these transactions, Samaha's indirect stake stands at 9,167,489 shares."
datetime: "2026-07-08T20:14:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292110097.md)
  - [en](https://longbridge.com/en/news/292110097.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292110097.md)
generator: "portal-rs"
---

# Theravance Biopharma 10% owner Eli Samaha disposes of USD 119,359 in common shares

-   Theravance Biopharma 10% owner Eli Samaha disclosed sales totaling 6,964 common shares on July 6-7. \* Shares sold at $17.04 on July 6, weighted-average $17.17 on July 7. \* Indirect stake reported at 9,167,489 shares following the July 7 transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001877589-26-000002), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TBPH.US](https://longbridge.com/en/quote/TBPH.US.md)

## Related News & Research

- [Theravance Biopharma reports CYPRESS Phase 3 miss but FDA grants Type C meeting to discuss future trial](https://longbridge.com/en/news/296955575.md)
- [Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH](https://longbridge.com/en/news/295997292.md)
- [Lexicon to present at Citi Biopharma Back to School investor conference](https://longbridge.com/en/news/297692441.md)
- [Redhill Biopharma Stock Doubles In One Session — Here's Why](https://longbridge.com/en/news/297531464.md)
- [Omeros VP, General Counsel Peter B. Cancelmo sells USD 927,167 of common shares](https://longbridge.com/en/news/297696692.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**